NCT05952544Completed
Effect of Protein Restriction Plus EAA/KA Supplementation on GFR Decline in CKD
Does Protein Restriction Plus Essential Amino Acids and Keto-analogues Supplementation Have a Beneficial Effect on GFR Decline in CKD Patients?
Source: ClinicalTrials.gov · Last updated 19 Aug 2024
Brief summary (registry, in English)
This study aims to investigate the effect of protein restriction plus KA/EAA supplementation on GFR decline in CKD patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 400 (actual)
- First submitted
- 1 Jul 2023
- Start date
- 20 Jul 2023
- Primary completion date
- 30 Mar 2024
- Lead sponsor
- Alexandria University
- Diseases
- Chronic kidney disease
- NCT number
- NCT05952544
What you commit to
- Study type: Observational
- Participants enrolled: 400
- From 20 Jul 2023 to the primary completion date, 30 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Active malignancy
- Advanced organ disease
Other
- Protein energy wasting
- pregnancy
Who the study is looking for
- Patients with CKD stages (G2 to G4), aged ≥ 18 years old
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Faculty of Medicine, Aexandria University Coordinator of this site? Confirm its status | Alexandria | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.